Press Releases

March 25 2014

The Biotechnology Industry Organization (BIO) and the Indiana Health Industry Forum (IHIF)...

March 5 2014

Many of the provisions included in this budget proposal would jeopardize the continued biotech...

January 30 2014

Patients Should Be Informed if Doctor's Prescription Changed

January 14 2014

Spending plan would enable the FDA to access $85 million in sequestered user fees

January 13 2014

BIO expresses strong support for the “Bipartisan Congressional Trade Priorities Act of...

January 9 2014

Nature Biotechnology published ...

November 18 2013

BIO commends the Senate for approving H.R. 3204, the Drug Quality and Security Act.

November 6 2013

Bill will encourage investment in growing innovative companies

August 21 2013

BIO applauds Rep. Michael Burgess (R-TX) and Rep. Jackie Speier (D-CA) for introducing the...

August 1 2013

S. 1413 and H.R. 2725 would exempt future FDA user fees from sequestration.

July 10 2013

H.R. 2629 will cut compliance costs for innovative emerging biotech companies

May 24 2013

Rx Response elevates to Alert status to address potential impact from Moore tornado on supply...

February 28 2013

BIO lauds the Senate for passing H.R. 307, the Pandemic and All-Hazards Preparedness...

January 25 2013

Bill will accelerate R&D to help support nation’s preparedness against chemical,...

October 1 2012

Pharmaceutical Research and Manufacturers of America PhRMA President and CEO John J....

July 23 2012

Groups issue booklet to help biotechnology and pharmaceutical companies identify pipeline...

June 28 2012

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the...

June 27 2012

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

May 24 2012

BIO commends the bipartisan Senate approval of FDASIA, which includes a reauthorization of the...

May 24 2012

BIO applauds Senator Robert Menendez for introducing the “The Extension of the Therapeutic...

April 24 2012

The Biotechnology Industry Organization (BIO) announced today its selection of Senator Michael...

April 24 2012

The Biotechnology Industry Organization (BIO) announced today its selection of Representative...

April 24 2012

The Biotechnology Industry Organization (BIO) announced today its selection of Senator Kay...

April 24 2012

The Biotechnology Industry Organization (BIO) announced today its selection of Representative...

April 24 2012

The Biotechnology Industry Organization (BIO) announced today its selection of Senator Robert...

April 24 2012

The Biotechnology Industry Organization (BIO) announced today its selection of Representative...

April 17 2012

The Biotechnology Industry Organization (BIO) submitted comments yesterday to the U.S. Food...

March 28 2012

H.R. 4274 will encourage continued investment in pediatric research.

March 6 2012

The FAST Act will modernize the Accelerated Approval pathway to expedite the...

February 15 2012

The bill will modernize the FDA and accelerate patient access to cures and new treatments.

February 14 2012

“The biotechnology industry has long been an engine for economic development and job...

February 9 2012

BIO President and CEO Jim Greenwood issued the following statement regarding the newly...

January 12 2012

Biotechnology Industry Organization (BIO) announces programming for 2012 event, to be held in...

November 15 2011

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following...

September 20 2011

Elaine Chao will provide a keynote address at the upcoming inaugural BIO China International...

September 1 2011

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

July 27 2011

BIO praised today’s ruling by a U.S. District Court dismissing a lawsuit that sought to...

June 28 2011

BIO announced its endorsement of the “Joint Declaration on Cooperation in the Fight...

June 15 2011

High-level members of the Obama Administration will gather with leaders from the...

May 25 2011

BIO commends Reps. Davis (D-Ca) and Schwartz (D-PA) for their continued efforts to extend the...

May 4 2011

BIO announces selection of Congressman Fred Upton (R-MI) as Legislator of the Year for 2010 -...

May 4 2011

BIO announced today its selection of Senator Bob Casey (D-PA) as Legislator of the Year for...

May 4 2011

BIO announces its selection of Representative David E. Price (D-NC) as Legislator of the Year...

May 4 2011

BIO announces its selection of Michael Capuano (D-MA) as Legislator of the Year for 2010 -...

May 4 2011

The Biotechnology Industry Organization (BIO) announced today its selection of Representative...

May 4 2011

The Biotechnology Industry Organization (BIO) announced today its selection of Congressman...

May 3 2011

BIO along with the Juvenile Diabetes Research Foundation (JDRF) will feature a two-day...

April 19 2011

BIO announces that Dr. Jörg Reinhardt, CEO of Bayer HealthCare, will provide the keynote...

April 19 2011

Democratic and Republican party leaders and strategists will share their differing...

March 16 2011

NIH Director Francis Collins, MD, PhD will share his insights on how ground-breaking biotech...

February 22 2011

BIO issues statement commending today’s ruling by the U.S. Supreme Court in ...

February 14 2011

Biotechnology Industry Organization (BIO) Industry Analysis and  BioMedTracker (BMT)...

February 9 2011

BIO announces that former Senator John B. Breaux (D-LA), former Member, Senate Finance...

January 26 2011

BIO's commends President Obama for highlighting the need to increase our nation...

January 12 2011

Experts chosen to speak on these panels represent leading clinical institutions, medical...

January 6 2011

BIO releases a report by Health Advances on the limitations of the nation’s...

January 3 2011

The 2011 BIO International Convention will highlight the latest trends and the newest...

September 29 2010

BIO President and CEO Jim Greenwood released the following statement on action by the U.S....

August 24 2010

BIO President and CEO Jim Greenwood issued the following statement today regarding the...

May 4 2010

A new report issued by the Biotechnology Industry Organization underscores how biotechnology...

March 22 2010

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

October 15 2009

The Biotechnology Industry Organization (BIO) today announced Plenary Session and Business...

March 9 2009

BIO lauded President Barack Obama’s Executive Order to allow the National Institutes of...

June 18 2008

BIO announced today the release of a paper outlining incentives to encourage innovation for...

September 21 2007

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

September 19 2007

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

April 12 2007

Jim Greenwood, President and CEO of the BIO, issued the following statement on S. 5, the Stem...

April 12 2007

S. 3 Would Weaken Medicare Part D Drug Benefit

April 10 2007

The widening use of new, innovative biopharmaceutical treatments for diseases, such as cancer,...

February 26 2007

Private Sector Negotiations for Medicare Part D Provide Savings and Access to Innovative...

January 11 2007

The recommended improvements to the Prescription Drug User Fee Act (PDUFA) announced today by...

November 25 2003

Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the...

May 22 2002

The House of Representatives today voted 425-1 to approve “The Public Health Security...

June 30 1999

 The American Hospital Association and BIO have signed a memorandum of understanding to...

November 12 1998

Carl B Feldbaum, president of  BIO, today issued the following statement on the need for...

July 22 1998

BIO is not surprised to learn that the Roslin Institute has verified the origins of Dolly the...

February 11 1998

Carl B. Feldbaum, president of BIO today issued the following statement after the Senate voted...

January 7 1998

Carl B. Feldbaum, president of BIO, today issued the following statement in response to news...

June 7 1997

Carl B. Feldbaum, president of BIO, issued the following statement today in response to the...

March 14 2014
The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA or Agency) for the opportunity to submit comments on the "Proposed Rule: Supplemental Applications Proposing Labelling Changes for Approved Drugs and Biological Products."
March 10 2014
The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments to the docket regarding “Complex Issues in Developing Drug and Biologics Products for Rare Diseases.” Comments are being provided in two areas; general comments on the challenges of rare disease drug development, and specific comments in response to the public workshop.
March 4 2014
The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the “Request for Nominations: Drug Products that Present Demonstrable Difficulties for Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.”
February 3 2014
The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the “Draft Guidance for Industry on Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act.”
January 31 2014
The Biotechnology Industry Organization (BIO) respectfully submits these comments in response to the Generic Pharmaceutical Association (GPhA) Citizen Petition requesting the Food and Drug Administration (FDA) to “implement its INN naming policy equally to all biologics” and to require “all biologics approved under the Section 351(k) pathway…share the same INN [International Nonproprietary Name] as the RPP [reference protein product]” (the GPhA Petition).
April 7 2014
The EXPIRE Act would extend tax credits that expired at the end of 2013, including several of importance to the biotechnology industry.
March 25 2014
The Biotechnology Industry Organization (BIO) and the Indiana Health Industry Forum (IHIF) commend Indiana Governor Mike Pence for signing legislation today designed to create a pathway for the substitution of interchangeable biologic medicines.
March 5 2014
Many of the provisions included in this budget proposal would jeopardize the continued biotech research and development that is necessary to find cures and breakthrough medicines for patients living with debilitating and life-threatening diseases. 
January 30 2014
Patients Should Be Informed if Doctor's Prescription Changed